HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Positive inotropic substances in therapy of heart failure: digitalis, catecholamines, phosphodiesterase inhibitors].

Abstract
The discussion about the importance of inotropic agents in the treatment of congestive heart failure is still open. A review of studies concerning the effects of digitalis, adrenoceptor stimulating or blocking agents, as well as phosphodiesterase inhibitors on hemodynamics and the physical state of heart failure patients is presented. Most authors agree that digitalis is indicated in patients with impaired left ventricular function and supraventricular arrhythmias, as well as in patients with heart failure who remain symptomatic during treatment with diuretics and vasodilators. While adrenoceptor stimulation with catecholamines is widely accepted in patients with acute and severe heart failure, beta-receptor blockers seem to have beneficial effects on some patients with mild to moderate congestive heart failure.
AuthorsT Stefenelli
JournalActa medica Austriaca (Acta Med Austriaca) Vol. 18 Issue 4 Pg. 81-5 ( 1991) ISSN: 0303-8173 [Print] Austria
Vernacular TitlePositiv inotrope Substanzen in der Therapie der Herzinsuffizienz: Digitalis, Katecholamine, Phosphodiesteraseinhibitoren.
PMID1763582 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Cardiotonic Agents
  • Catecholamines
  • Digitalis Glycosides
  • Phosphodiesterase Inhibitors
Topics
  • Cardiotonic Agents (therapeutic use)
  • Catecholamines (therapeutic use)
  • Digitalis Glycosides (therapeutic use)
  • Heart Failure (drug therapy)
  • Hemodynamics (drug effects)
  • Humans
  • Phosphodiesterase Inhibitors (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: